Pongchaiyakul Chatlert, Panichkul Suthee, Songpatanasilp Thawee
Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
J Med Assoc Thai. 2007 Oct;90(10):2016-23.
To examine the diagnostic performance of clinical risk indices combined with quantitative ultrasound calcaneus measurement (QUS) for identifying osteoporosis in Thai postmenopausal women.
The present study was designed as a cross-sectional investigation in 300 Thai women, aged between 38 and 85 years (mean age: 58). Femoral neck bone mineral density (BMD) was measured by DXA (Hologic QDR-4500; Hologic, Bedford, MA, USA). A BMD T-scores < or = -2.5 was defined as "osteoporosis"; otherwise, "non-osteoporosis". QUS was measured by Achilles+ (GE Lunar, Madison, WI, USA) and converted to T-score. The OSTA and KKOS score was calculated for each woman using her age and weight Women with OSTA/KKOS scores < or = -1 and > -1 were classified as "high risk" and "low risk", respectively.
Using DXA as the gold standard, the sensitivity of QUS to identify osteoporosis was lower than the sensitivity of OSTA/KKOS (60 vs. 71/74%) but the specificity and PPV of QUS were higher than OSTA/KKOS. The sensitivity increased when using OSTA/KKOS combined with QUS to identify osteoporosis (approximately 87-89%) while the specificity, PPV and NPV were comparable with using clinical risk indices alone. The risk (odds ratio; OR) of osteoporosis when QUS T-score < or = -2.5 alone was 9.94 (95%CI: 4.74-20.87), which was higher than high risk by OSTA/KKOS alone (OR: 6.35, 95%CI: 2.99-13.47 for OSTA and 8.15, 95%CI: 3.76-17.66 for KKOS). Furthermore, individuals were classified "high risk" from OSTA/KKOS with QUS T-score < or = -2.5SD, the risk of osteoporosis was increased (OR: 43.68, 95%CI: 13.89-137.36 and OR: 60.92, 95%CI: 17.69-209.76 for OSTA and KKOS, respectively).
Using the clinical risk indices combined with QUS could improve the accuracy of osteoporosis identification. This approach could be used in a primary care setting or community-based hospital where a DXA machine is not available.
探讨临床风险指数联合定量跟骨超声测量(QUS)对泰国绝经后女性骨质疏松症的诊断效能。
本研究为横断面调查,纳入300名年龄在38至85岁之间(平均年龄:58岁)的泰国女性。采用双能X线吸收法(DXA,美国马萨诸塞州贝德福德市Hologic公司的QDR - 4500型)测量股骨颈骨密度(BMD)。BMD T值≤ -2.5被定义为“骨质疏松症”;否则为“非骨质疏松症”。使用美国威斯康星州麦迪逊市GE Lunar公司的Achilles+仪器测量QUS并转换为T值。根据每位女性的年龄和体重计算OSTA和KKOS评分。OSTA/KKOS评分≤ -1和> -1的女性分别被归类为“高风险”和“低风险”。
以DXA作为金标准,QUS诊断骨质疏松症的敏感性低于OSTA/KKOS(60%对71%/74%),但QUS的特异性和阳性预测值高于OSTA/KKOS。当联合使用OSTA/KKOS和QUS诊断骨质疏松症时,敏感性增加(约87% - 89%),而特异性、阳性预测值和阴性预测值与单独使用临床风险指数时相当。单独QUS T值≤ -2.5时患骨质疏松症的风险(比值比;OR)为9.94(95%可信区间:4.74 - 20.87),高于单独OSTA/KKOS高风险(OSTA的OR:6.35,95%可信区间:2.99 - 13.47;KKOS的OR:8.15,95%可信区间:3.76 - 17.66)。此外,对于OSTA/KKOS分类为“高风险”且QUS T值≤ -2.5标准差的个体,患骨质疏松症的风险增加(OSTA的OR:43.68,95%可信区间:13.89 - 137.36;KKOS的OR:60.92,95%可信区间:17.69 - 209.76)。
联合使用临床风险指数和QUS可提高骨质疏松症诊断的准确性。这种方法可用于基层医疗环境或没有DXA设备的社区医院。